(Q73158685)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

8

G Fountzilas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

G Aravantinos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D V Skarlos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P Kosmidis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Athanassiades

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D Bafaloukos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Giannakakis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Karpathios

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

160-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900366-8

7 January 2021

10.1016/S0959-8049(96)00366-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9071916%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference